| T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors T Yamauchi, T Hoki, T Oba, V Jain, H Chen, K Attwood, S Battaglia, ... Nature communications 12 (1), 1402, 2021 | 117 | 2021 |
| Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma S Tanaka, K Miyanishi, M Kobune, Y Kawano, T Hoki, T Kubo, T Hayashi, ... Journal of Gastroenterology 48 (11), 1249-1258, 2013 | 109 | 2013 |
| Increased duodenal iron absorption through up‐regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic … T Hoki, K Miyanishi, S Tanaka, K Takada, Y Kawano, A Sakurada, M Sato, ... Hepatology 62 (3), 751-761, 2015 | 68 | 2015 |
| CX3CR1–CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment T Yamauchi, T Hoki, T Oba, H Saito, K Attwood, MS Sabel, AE Chang, ... JCI insight 5 (8), e133920, 2020 | 62 | 2020 |
| Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy K Miyanishi, T Hoki, S Tanaka, J Kato World Journal of Hepatology 7 (3), 593-599, 2015 | 30 | 2015 |
| A critical role of CD40 and CD70 signaling in conventional type 1 dendritic cells in expansion and antitumor efficacy of adoptively transferred tumor-specific T cells T Oba, T Hoki, T Yamauchi, T Keler, HC Marsh, X Cao, F Ito The Journal of Immunology 205 (7), 1867-1877, 2020 | 23 | 2020 |
| Low DMT1 expression associates with increased oxidative phosphorylation and early recurrence in hepatocellular carcinoma T Hoki, E Katsuta, L Yan, K Takabe, F Ito journal of surgical research 234, 343-352, 2019 | 21 | 2019 |
| CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells T Yamauchi, T Hoki, T Oba, R Kajihara, K Attwood, X Cao, F Ito Cancer Immunology, Immunotherapy 71 (1), 137-151, 2022 | 15 | 2022 |
| Two cases of liver abscess caused by Clostridium perfringens that potentially cured by combined modality therapy T Kubo, Y Kawano, K Miyanishi, K Ishikawa, A Sakurada, M Sato, T Hoki, ... Kanzo 58 (2), 105-114, 2017 | 8* | 2017 |
| Identification of dysfunctional CD8+ T-cell subsets rescued by PD-L1 blockade in the tumor microenvironment T Yamauchi, T Hoki, K Odunsi, F Ito The Journal of Immunology 200 (1_Supplement), 58.3, 2018 | 5 | 2018 |
| Frequency of circulating CX3CR1+ CD8+ T cells to predict response to immune checkpoint inhibitor therapy T Yamauchi, T Hoki, T Oba, K Attwood, S Battaglia, I Puzanov, H Chen, ... Cancer Research 80 (16_Supplement), 1044-1044, 2020 | 4 | 2020 |
| A long-term survival case of hepatic epithelioid hemangioendothelioma with lung metastases treated with recombinant interleukin-2 T Hoki, K Miyanishi, Y Kawano, S Yamada, K Harada, M Hirakawa, ... Kanzo 56 (7), 356-365, 2015 | 4* | 2015 |
| Synergistic anti-tumor efficacy of combined TLR3 and CD40 neoantigen vaccine requires Batf3-dependent dendritic cells T Hoki, T Yamauchi, K Odunsi, F Ito The Journal of Immunology 200 (1_Supplement), 181.7, 2018 | 3 | 2018 |
| A case of acquired fanconi's syndrome and hypophosphatemic osteomalacia induced by prolonged adefovir therapy for chronic hepatitis B K Ishikawa, K Miyanishi, T Hoki, F Tamura, Y Kawano, K Takada, ... Kanzo 55 (3), 162-169, 2014 | 3* | 2014 |
| Chronic hepatitis C presenting with hepatic involvement by chronic lymphocytic leukemia responding to polyethylene glycol interferon-α-2b T Hoki, H Kuroda, K Ishikawa, Y Okagawa, M Yamada, T Sakurai, S Fujii, ... Gan to Kagaku ryoho. Cancer & Chemotherapy 39 (10), 1551-1554, 2012 | 3 | 2012 |
| Generation, transcriptomic states, and clinical relevance of CX3CR1+ CD8 T cells in melanoma H Ishigaki, T Yamauchi, MD Long, T Hoki, Y Yamamoto, T Oba, F Ito Cancer Research Communications, 2024 | 1 | 2024 |
| A critical role of CD40 and CD70 signaling in cDC1s in expansion and antitumor efficacy of adoptively transferred tumor-specific T cells T Oba, T Hoki, T Yamauchi, T Keler, HC Marsh, X Cao, F Ito Journal of immunology (Baltimore, Md.: 1950) 205 (7), 1867, 2020 | 1 | 2020 |
| Bendamustine-rituximab therapy is effective for transformed follicular lymphoma with significant expression of p53 H Kuroda, W Jomen, S Miura, Y Arihara, M Yamada, T Hirako, T Abe, ... Gan to Kagaku ryoho. Cancer & Chemotherapy 40 (8), 1055-1058, 2013 | 1 | 2013 |
| Circulating CX3CR1+ CD8+ T Cells to Predict Response to Chemo-Immunotherapy in Patients with Non-Small Cell Lung Cancer EN Abdelfatah, T Hoki, T Oba, HN Chen, K Attwood, B Segal, F Ito, ... Journal of the American College of Surgeons 233 (5), S244-S245, 2021 | | 2021 |
| Circulating T-Cell Biomarkers to Predict Response to Immune Checkpoint Inhibitors T Yamauchi, T Hoki, H Chen, S George, G Dy, GS Chatta, I Puzanov, ... Journal of the American College of Surgeons 227 (4), e56, 2018 | | 2018 |
Fumito ItoUniversity of Southern California在 med.usc.edu 的电子邮件经过验证
